UIM
IONS icon

USS Investment Management’s Ionis Pharmaceuticals IONS Stock Holding History

USS Investment Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,363
Closed -$334K – 714
2021
Q2 		$334K Hold
8,363
– – ﹤0.01% 607
2021
Q1 		$376K Hold
8,363
– – ﹤0.01% 589
2020
Q4 		$473K Hold
8,363
– – ﹤0.01% 570
2020
Q3 		$397K Hold
8,363
– – ﹤0.01% 568
2020
Q2 		$493K Buy
+8,363
New +$465K 0.01% 543

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

USS Investment Management's IONS Position: Q3 2021 in Review

USS Investment Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2021, closing a stake of 8,363 shares — an estimated $334K sold.

USS Investment Management first reported a position in IONS in Q2 2020 and held it in 5 quarters. The position peaked at $493K in Q2 2020. 324 funds tracked by Wall St. Rank hold IONS as of Q3 2021.

  • USS Investment Management reported no remaining Ionis Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • USS Investment Management sold 8,363 Ionis Pharmaceuticals shares in Q3 2021, an estimated $334K.
  • USS Investment Management first reported a position in Ionis Pharmaceuticals in Q2 2020 and held it in 5 quarters.
  • USS Investment Management's Ionis Pharmaceuticals position peaked at $493K in Q2 2020.
  • 324 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2021.

Based on USS Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.